Close Menu

NEW YORK (GenomeWeb) – MDxHealth reported today that its third quarter revenues rose 122 percent, driven by a sharp increase in the number of payors issuing positive coverage decisions for its ConfirmMDx and SelectMDx prostate cancer tests.

For the three months ended Sept. 30, the Belgian molecular diagnostics company said revenues rose to $9.1 million from $4.1 million in Q3 2015.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.

A controversial paper on the gender gap in science has been corrected, according to BuzzFeed News.

The Los Angeles Times reports that only a third of California students meet the state's new science standards.

In Science this week: evidence of interbreeding between the ancestors of West Africans and an unknown archaic human, and more.